What is the current annual EBITDA of ARGX?

As of today, ARGX annual EBITDA is $1.02B

What is 1-year change in ARGX annual EBITDA?

ARGX annual EBITDA is up +2304.65% year-over-year

What is 3-year change in ARGX annual EBITDA?

ARGX annual EBITDA is up +259.28% over the past 3 years

How far is ARGX annual EBITDA from its all-time high?

ARGX annual EBITDA is currently at its all-time high

How does ARGX annual EBITDA rank versus sector peers?

ARGX annual EBITDA is higher than 93.09% of companies in Healthcare sector

When is ARGX next annual earnings release?

The next annual earnings release for ARGX is on February 25, 2027

What is the current quarterly EBITDA of ARGX?

As of today, ARGX quarterly EBITDA is $531.00M

What is ARGX quarterly EBITDA most recent change?

ARGX quarterly EBITDA was down -1.85% on September 30, 2026

What is 1-year change in ARGX quarterly EBITDA?

ARGX quarterly EBITDA is up +36.50% year-over-year

How far is ARGX quarterly EBITDA from its all-time high?

ARGX quarterly EBITDA is currently -1.85% below its historical high of $541.00M set on June 30, 2026

How does ARGX quarterly EBITDA rank versus sector peers?

ARGX quarterly EBITDA is higher than 95.33% of companies in Healthcare sector

When is ARGX next earnings release?

The next earnings release for ARGX is on February 25, 2027

What is the current TTM EBITDA of ARGX?

As of today, ARGX TTM EBITDA is $1.91B

What is ARGX TTM EBITDA most recent change?

ARGX TTM EBITDA was up +8.03% on September 30, 2026

What is 1-year change in ARGX TTM EBITDA?

ARGX TTM EBITDA is up +391.23% year-over-year

How far is ARGX TTM EBITDA from its all-time high?

ARGX TTM EBITDA is currently at its all-time high

How does ARGX TTM EBITDA rank versus sector peers?

ARGX TTM EBITDA is higher than 95.13% of companies in Healthcare sector

When is ARGX next earnings release?

The next earnings release for ARGX is on February 25, 2027

Argenx SE (ARGX) EBITDA History & Chart Since 2011

Annual EBITDA

$1.02B$1.07B+2,304.65%

December 31, 2025

Summary

Current Value: As of today, ARGX annual EBITDA is $1.02B, up +2304.65% on December 31, 2025
Historical Performance: ARGX annual EBITDA is up +259.28% over the past 3 years, up +307.92% over the past 5 years
All-Time High Comparison: ARGX annual EBITDA is currently at its all-time high
3-Year Low Comparison: ARGX annual EBITDA is +259.28% above its 3-year low of -$641.62M reached on an earlier date
Sector Comparison: ARGX annual EBITDA is higher than 93.09% of companies in Healthcare sector

EBITDA Chart

beforeafter

Performance

ARGX Performance
Metric	Date	Value	1Y	3Y	5Y	15Y
Annual EBITDA	Dec 31, 25	$1.02B	+2304.7%	+259.3%	+307.9%	–
Quarterly EBITDA	Sep 30, 26	$531.00M	+36.5%	–	+339.3%	+10000.0%
TTM EBITDA	Sep 30, 26	$1.91B	+391.2%	–	+961.1%	+10000.0%
Price	Nov 4, 26	$931.38	+12.0%	+86.3%	+181.7%	–
PE Ratio	Nov 4, 26	69.92	-56.4%	–	–	–
Annual Revenue	Dec 31, 25	$4.17B	+90.6%	+913.8%	+9935.4%	–
Annual EPS	Dec 31, 25	$19.63	+53.8%	+250.3%	+245.5%	–
	Dec 31, 25	$993.75M	+1656.4%	+233.2%	+300.6%	–
Annual Net Income	Dec 31, 25	$1.30B	+55.9%	+282.5%	+311.6%	–

EBITDA Highs

ARGX Annual EBITDA Highs Comparison
Period	High	Date	Current
3Y	$1.02B	Dec 31, 25	at high
5Y	$1.02B	Dec 31, 25	at high
All	$1.02B	Dec 31, 25	at high

EBITDA Lows

ARGX Annual EBITDA Lows Comparison
Period	Low	Date	Current
3Y	-$641.62M	N/A	+259.3%
5Y	-$641.62M	Dec 31, 22	+259.3%
All	-$641.62M	Dec 31, 22	+259.3%

EBITDA History

Year	Value	Change
2025	$1.02B	+2,304.6%
2024	-$46.35M	+86.4%
2023	-$340.21M	+47.0%
2022	-$641.62M	-72.6%
2021	-$371.82M	+24.4%
2020	-$491.51M	-137.9%
2019	-$206.60M	-105.2%
2018	-$100.69M	-226.7%

Year	Value	Change
2017	-$30.82M	-28.3%
2016	-$24.03M	-17.1%
2015	-$20.53M	-42.9%
2014	-$14.37M	-24.6%
2013	-$11.53M	+20.1%
2012	-$14.43M	-93.1%
2011	-$7.47M	-

FAQ

What is the current annual EBITDA of ARGX?: As of today, ARGX annual EBITDA is $1.02B
What is 1-year change in ARGX annual EBITDA?: ARGX annual EBITDA is up +2304.65% year-over-year
What is 3-year change in ARGX annual EBITDA?: ARGX annual EBITDA is up +259.28% over the past 3 years
How far is ARGX annual EBITDA from its all-time high?: ARGX annual EBITDA is currently at its all-time high
How does ARGX annual EBITDA rank versus sector peers?: ARGX annual EBITDA is higher than 93.09% of companies in Healthcare sector
When is ARGX next annual earnings release?: The next annual earnings release for ARGX is on February 25, 2027

EBITDA Formula

EBITDA = Net Income + + +

Quarterly EBITDA

$531.00M$10.00M-1.85%

September 30, 2026

Summary

Current Value: As of today, ARGX quarterly EBITDA is $531.00M, down -1.85% on September 30, 2026
Historical Performance: ARGX quarterly EBITDA is up +36.50% year-over-year
All-Time High Comparison: ARGX quarterly EBITDA is currently -1.85% below its historical high of $541.00M set on June 30, 2026
3-Year Low Comparison: ARGX quarterly EBITDA is +36.50% above its 3-year low of $389.00M reached on September 30, 2025
Sector Comparison: ARGX quarterly EBITDA is higher than 95.33% of companies in Healthcare sector

Performance

ARGX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
Quarterly EBITDA	Sep 30, 26	$531.00M	-1.9%	+36.5%	–	+339.3%
Annual EBITDA	Dec 31, 25	$1.02B	–	+2304.7%	+259.3%	+307.9%
TTM EBITDA	Sep 30, 26	$1.91B	+8.0%	+391.2%	–	+961.1%
Price	Nov 4, 26	$931.38	+10.3%	+12.0%	+86.3%	+181.7%
PE Ratio	Nov 4, 26	69.92	–	-56.4%	–	–
Quarterly Revenue	Sep 30, 26	$1.72B	+13.6%	+52.7%	–	+7250.9%
Quarterly EPS	Sep 30, 26	$7.80	–	+50.6%	–	+278.9%
	Sep 30, 26	$539.00M	+1.1%	+39.3%	–	+335.3%
Quarterly Net Income	Sep 30, 26	$506.00M	+7.2%	+47.1%	–	+322.7%

Quarterly EBITDA Highs

ARGX Quarterly EBITDA Highs Comparison
Period	High	Date	Current
1Y	$541.00M	Jun 30, 26	-1.9%
3Y	$541.00M	Jun 30, 26	-1.9%
5Y	$541.00M	Jun 30, 26	-1.9%
All	$541.00M	Jun 30, 26	-1.9%

Quarterly EBITDA Lows

ARGX Quarterly EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$389.00M	N/A	+36.5%
3Y	$389.00M	Sep 30, 25	+36.5%
5Y	-$221.91M	Mar 31, 22	+339.3%
All	-$221.91M	Mar 31, 22	+339.3%

Quarterly EBITDA History

Month	Value	Change
Sep 2026	$531.00M	-1.8%
Jun 2026	$541.00M	+23.5%
Mar 2026	$438.00M	+9.3%
Dec 2025	$400.90M	+3.1%
Sep 2025	$389.00M	+329.3%
Jun 2022	-$169.63M	+23.6%
Mar 2022	-$221.91M	-4,788.7%

Month	Value	Change
Jun 2014	-$4.54M	-39.7%
Mar 2014	-$3.25M	-65.3%
Dec 2013	-$1.97M	-1,860.0%
Sep 2013	-$100.30K	+97.5%
Jun 2013	-$3.97M	-68.0%
Mar 2013	-$2.36M	-

FAQ

What is the current quarterly EBITDA of ARGX?: As of today, ARGX quarterly EBITDA is $531.00M
What is ARGX quarterly EBITDA most recent change?: ARGX quarterly EBITDA was down -1.85% on September 30, 2026
What is 1-year change in ARGX quarterly EBITDA?: ARGX quarterly EBITDA is up +36.50% year-over-year
How far is ARGX quarterly EBITDA from its all-time high?: ARGX quarterly EBITDA is currently -1.85% below its historical high of $541.00M set on June 30, 2026
How does ARGX quarterly EBITDA rank versus sector peers?: ARGX quarterly EBITDA is higher than 95.33% of companies in Healthcare sector
When is ARGX next earnings release?: The next earnings release for ARGX is on February 25, 2027

EBITDA Formula

EBITDA = Net Income + + +

TTM EBITDA

$1.91B$142.00M+8.03%

September 30, 2026

Summary

Current Value: As of today, ARGX TTM EBITDA is $1.91B, up +8.03% on September 30, 2026
Historical Performance: ARGX TTM EBITDA is up +391.23% year-over-year
All-Time High Comparison: ARGX TTM EBITDA is currently at its all-time high
3-Year Low Comparison: ARGX TTM EBITDA is +391.23% above its 3-year low of $389.00M reached on September 30, 2025
Sector Comparison: ARGX TTM EBITDA is higher than 95.13% of companies in Healthcare sector

Performance

ARGX Performance
Metric	Date	Value	3M	1Y	3Y	5Y
TTM EBITDA	Sep 30, 26	$1.91B	+8.0%	+391.2%	–	+961.1%
Annual EBITDA	Dec 31, 25	$1.02B	–	+2304.7%	+259.3%	+307.9%
Quarterly EBITDA	Sep 30, 26	$531.00M	-1.9%	+36.5%	–	+339.3%
Price	Nov 4, 26	$931.38	+10.3%	+12.0%	+86.3%	+181.7%
PE Ratio	Nov 4, 26	69.92	–	-56.4%	–	–
TTM Revenue	Sep 30, 26	$5.82B	+11.4%	+416.6%	–	+10000.0%
TTM EPS	Sep 30, 26	$13.32	–	+157.1%	–	+405.5%
	Sep 30, 26	$1.90B	+8.7%	+391.8%	–	+930.6%
TTM Net Income	Sep 30, 26	$1.88B	+9.4%	+445.6%	–	+926.2%

TTM EBITDA Highs

ARGX TTM EBITDA Highs Comparison
Period	High	Date	Current
1Y	$1.91B	Sep 30, 26	at high
3Y	$1.91B	Sep 30, 26	at high
5Y	$1.91B	Sep 30, 26	at high
All	$1.91B	Sep 30, 26	at high

TTM EBITDA Lows

ARGX TTM EBITDA Lows Comparison
Period	Low	Date	Current
1Y	$389.00M	N/A	+391.2%
3Y	$389.00M	Sep 30, 25	+391.2%
5Y	-$391.54M	Jun 30, 22	+588.0%
All	-$391.54M	Jun 30, 22	+588.0%

TTM EBITDA History

Month	Value	Change
Sep 2026	$1.91B	+8.0%
Jun 2026	$1.77B	+44.1%
Mar 2026	$1.23B	+55.4%
Dec 2025	$789.90M	+103.1%
Sep 2025	$389.00M	+199.4%
Jun 2022	-$391.54M	-76.4%
Mar 2022	-$221.91M	-2,151.6%

Month	Value	Change
Jun 2014	-$9.86M	-6.2%
Mar 2014	-$9.28M	-10.6%
Dec 2013	-$8.39M	-30.6%
Sep 2013	-$6.43M	-1.6%
Jun 2013	-$6.33M	-168.0%
Mar 2013	-$2.36M	-

FAQ

What is the current TTM EBITDA of ARGX?: As of today, ARGX TTM EBITDA is $1.91B
What is ARGX TTM EBITDA most recent change?: ARGX TTM EBITDA was up +8.03% on September 30, 2026
What is 1-year change in ARGX TTM EBITDA?: ARGX TTM EBITDA is up +391.23% year-over-year
How far is ARGX TTM EBITDA from its all-time high?: ARGX TTM EBITDA is currently at its all-time high
How does ARGX TTM EBITDA rank versus sector peers?: ARGX TTM EBITDA is higher than 95.13% of companies in Healthcare sector
When is ARGX next earnings release?: The next earnings release for ARGX is on February 25, 2027

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

ARGX Official Website argenx.com
ARGX Profile on Yahoo Finance finance.yahoo.com/quote/ARGX
ARGX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/argx